To include your compound in the COVID-19 Resource Center, submit it here.

Exenatide-XTEN: Phase I data

An ongoing, double-blind, placebo-controlled Phase I trial in 31 evaluable patients showed that single subcutaneous injections of

Read the full 179 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE